The increase in M2 macrophages was associated with increased levels of interleukin (IL)‐6 and prostaglandin E2 (PGE2), two inflammatory mediators known to skew the differentiation of monocytes to tumor‐promoting M2 macrophages.27 The gene discussed is IL6; the disease is neoplasm.